Stay updated on Durvalumab and Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelimumab in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added a new revision entry v3.6.0 with a recruitment status note 'No longer looking for participants.' The previous revision entry v3.5.5 was removed.
    Difference
    0.2%
    Check dated 2026-06-12T13:35:14.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5. This indicates a new release of the page rendering rather than any change to the underlying study information.
    Difference
    0.1%
    Check dated 2026-06-05T08:36:53.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    A new history entry was added on 2026-05-12 (Version 53) with Revision: v3.5.4. It includes a Study Status update in the Study Record Versions.
    Difference
    0.3%
    Check dated 2026-05-15T04:17:41.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.2 to v3.5.3, indicating a new version of the page's revision history. This reflects an update to the page's metadata without altering the underlying study data or functionality.
    Difference
    0.1%
    Check dated 2026-04-30T17:55:24.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision history updated: added v3.5.2 and removed v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:49:18.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Revision history shows an addition of v3.5.0 and a deletion of v3.4.3. These entries document the version updates for the page.
    Difference
    0.1%
    Check dated 2026-03-18T16:45:29.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.